Security key
92243G108
Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX)
CUSIP: 92243G108
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 145,782,011
- Total 13F shares
- 133,025,604
- Share change
- +2,883,189
- Total reported value
- $5,021,104,716
- Put/Call ratio
- 73%
- Price per share
- $37.76
- Number of holders
- 302
- Value change
- -$42,905,782
- Number of buys
- 176
- Number of sells
- 155
Report period
Q1 2025
Institutions
302
Top holders
10
PCVX full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Vaxcyte, Inc. SEC filings
Vaxcyte, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92243G108
Recent filing periods:
Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
11,106,069
|
$909,142,808 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
9%
|
13,091,648
|
$1,071,682,283 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.2%
|
11,961,687
|
$979,183,698 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
7.3%
|
10,575,363
|
$865,605,331 | — | 31 Dec 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6%
|
8,689,190
|
$711,297,093 | — | 31 Dec 2024 | |
| Capital Research Global Investors |
13F
|
Company |
4.3%
|
6,210,523
|
$508,393,413 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
4,539,406
|
$371,595,775 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3%
|
4,444,012
|
$363,786,823 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.7%
|
3,966,956
|
$324,736,000 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.1%
|
3,129,604
|
$256,189,383 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2%
|
2,869,332
|
$234,883,523 | — | 31 Dec 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2%
|
2,860,717
|
$234,179,000 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
2,802,888
|
$229,494,760 | — | 31 Dec 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.8%
|
2,566,759
|
$210,114,892 | — | 31 Dec 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.6%
|
2,336,796
|
$191,290,121 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.2%
|
1,779,362
|
$145,658,573 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
1,735,663
|
$142,081,421 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
1,718,417
|
$140,669,616 | — | 31 Dec 2024 | |
| Commodore Capital LP |
13F
|
Company |
1.1%
|
1,625,000
|
$133,022,500 | — | 31 Dec 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.98%
|
1,422,787
|
$116,469,344 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.92%
|
1,341,773
|
$109,837,538 | — | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.86%
|
1,246,551
|
$102,042,666 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.83%
|
1,212,706
|
$99,272,113 | — | 31 Dec 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
0.82%
|
1,201,898
|
$98,387,370 | — | 31 Dec 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.81%
|
1,175,000
|
$96,185,500 | — | 31 Dec 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.8%
|
1,166,833
|
$95,516,949 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.8%
|
1,166,054
|
$95,453,180 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.8%
|
1,160,001
|
$94,957,682 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.77%
|
1,120,922
|
$91,758,675 | — | 31 Dec 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.76%
|
1,102,486
|
$90,249,523 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.75%
|
1,100,286
|
$90,069,412 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.7%
|
1,017,845
|
$83,320,792 | — | 31 Dec 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.67%
|
973,645
|
$79,702,580 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.53%
|
775,653
|
$63,494,955 | — | 31 Dec 2024 | |
| Novo Holdings A/S |
13F
|
Company |
0.51%
|
750,000
|
$61,395,000 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.51%
|
736,561
|
$60,294,884 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.49%
|
716,773
|
$58,675,344 | — | 31 Dec 2024 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.48%
|
703,834
|
$57,615,851 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.48%
|
693,333
|
$56,756,295 | — | 31 Dec 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.42%
|
605,267
|
$49,547,265 | — | 31 Dec 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.41%
|
593,523
|
$49,418,422 | — | 31 Dec 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.4%
|
586,128
|
$47,980,438 | — | 31 Dec 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.38%
|
556,209
|
$45,531,269 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.37%
|
539,405
|
$44,155,693 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.36%
|
529,650
|
$43,357,149 | — | 31 Dec 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
523,007
|
$42,813,353 | — | 31 Dec 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.33%
|
486,764
|
$39,846,000 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.32%
|
472,964
|
$38,716,832 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.32%
|
469,911
|
$38,466,874 | — | 31 Dec 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.29%
|
425,000
|
$34,790,500 | — | 31 Dec 2024 |
Institutional Holders of Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) as of Q1 2025
As of 31 Mar 2025,
Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) was held by
302 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,025,604 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, Kynam Capital Management, LP, and FRANKLIN RESOURCES INC.
This page lists
306
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
318
Q1 2025 holders
302
Holder diff
-16
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.